Stay updated with breaking news from Advaxis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Cancer Immunotherapy Market by Product Type, Application, End Users, and Geography - Global Forecast up to 2026" report has been added to...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates UFS, HBMD, ICBK, ADXS; Shareholders are Encouraged to Contact the Firm NEW YORK, July 18, 2021 (GLOBE NEWSWIRE) — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Domtar Corporation (NYSE: UFS) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Paper Excellence for $55.50 per share in cash. If you are a Domtar shareholder, click here to learn more about your rights and options . Howard Bancorp, Inc. (NAS...
Share this article Share this article NEW YORK, July 16, 2021 /PRNewswire/-- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Advaxis, Inc. ("ADXS" or the "Company") (ADXS) relating to its proposed merger with BioSight Ltd. The investigation focuses on whether Advaxis, Inc. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company ...
Cancer vaccine is a type of immunotherapy that boosts the natural defense of body by stimulating the immune system to recognize and cure cancerous cel
Biotechnology Advaxis Inc is a clinical stage biotechnology company operating in the United States. It focuses on the discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology which utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company's immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADX...